Study finds ribociclib improves progression-free survival for women with metastatic breast cancer
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, ribociclib, in combination with the aromatase inhibitor letrozole, dramatically improved progression-free survival ...
Oct 11, 2016